APA (7th ed.) Citation

Swenson, C. E., Hunt, W. R., Manfredi, C., Beltran, D. J., Hong, J. S., Davis, B. R., . . . Sorscher, E. J. (2025). Evaluating elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta™) for treatment of patients with non-cystic fibrosis bronchiectasis (NCFBE): A clinical study protocol. PloS one, 20(2), e0316721. https://doi.org/10.1371/journal.pone.0316721

Chicago Style (17th ed.) Citation

Swenson, Colin E., et al. "Evaluating Elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta™) for Treatment of Patients with Non-cystic Fibrosis Bronchiectasis (NCFBE): A Clinical Study Protocol." PloS One 20, no. 2 (2025): e0316721. https://doi.org/10.1371/journal.pone.0316721.

MLA (9th ed.) Citation

Swenson, Colin E., et al. "Evaluating Elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta™) for Treatment of Patients with Non-cystic Fibrosis Bronchiectasis (NCFBE): A Clinical Study Protocol." PloS One, vol. 20, no. 2, 2025, p. e0316721, https://doi.org/10.1371/journal.pone.0316721.